跳至主要内容
临床试验/JPRN-UMIN000016681
JPRN-UMIN000016681已完成未知

Effect of Goreisan in preventing or reducing diarrhea in patients receiving concurrent chemoradiotherapy for cervical cancer - Effect of Goreisan in preventing or reducing chemoradiation-induced diarrhea

Chiba University Hospital0 个研究点目标入组 40 人开始时间: 2015年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Inflammatory bowel disease such as Crohn disease and ulcerative colitis 2) Severe hepatic dysfunction (aspartate aminotransferase or alanine aminotransferase >=100 U/L) 3) Severe renal dysfunction (serum creatinine >=1.5 mg/dL or blood urea nitrogen >=25 mg/dL) 4) Mental illness that may require the administration of antipsychotics, and dementia 5) Current use of other oriental medicine 6) A history of the hypersensitivity that is serious for the study medicine, or drug allergy 7) Any case that the chief physician judges to be inadequate.

研究者

相似试验